fda glp-1 compounding enforcement november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Ban on Compounded GLP-1

609 Edaravone inhibits ferroptosis through the SIRT1/Nrf2 signaling pathway and has therapeutic potential for depression, TBI and stroke

Research suggests that by maintaining the glutathione redox balance and aerobic capacity mechanisms , athletes can sustain higher workloads for longer periods before hitting the wall. When paired with magnesiums ability to optimize cardiac output efficiency, the result is a significant boost in VO2 max and overall stamina

Many people are suffering needlessly with MCAS due to an environmental trigger or a susceptibility that hasnt been found

Reconstitute using bacteriostatic water or laboratory-grade solvents appropriate to the assay

Florida Surgery and Weight Loss Center provides medically supervised weight loss care and can help patients understand dosing instructions, pharmacy labeling, and treatment planning

If swallowing capsules is an issue for you, we recommend Kaged Clean Burn, which is a dissolvable powder